WebWhen satisfactory control of seizures has been attained, monotherapy with Keppra may be envisaged by progressively decreasing and withdrawing the concomitant antiepileptic medication. Elderly (65 years and older) Adjustment of the dose is recommended in the elderly with compromised renal function (see Patients with renal impairment below). WebAcute kidney injury; agranulocytosis; bone marrow disorders; delirium; encephalopathy; gait abnormal; hepatic disorders; hyponatraemia; neutropenia; pancreatitis; personality disorder; QT interval prolongation; rhabdomyolysis; seizures exacerbated; severe cutaneous adverse reactions (SCARs); thinking abnormal Frequency not known
HIGHLIGHTS OF PRESCRIBING INFORMATION KEPPRA KEPPRA.
WebKeppra disease interactions. There are 4 disease interactions with Keppra (levetiracetam) which include: suicidal tendency. hemodialysis. renal dysfunction. hematologic abnormalities. Web3 sep. 2024 · KEPPRA (levetiracetam) 500 mg/5 mL injection is a clear, colorless, sterile solution. It is supplied in single-use 5 mL vials, available in cartons of 10 vials (NDC 50474-002-63). Storage. Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. palbociclib and anastrozole
Cyclosporine and tacrolimus nephrotoxicity - UpToDate
Web4 mrt. 2024 · Kidney function and non-kidney solid organ transplantation; Kidney transplantation in adults: Chronic allograft nephropathy; Kidney transplantation in adults: … Web27 feb. 2024 · Causes of high creatinine levels. High creatinine levels usually indicate that the kidneys are not working as they should. Possible causes of this dysfunction include: a kidney infection ... WebDo not take Keppra. If you are allergic to levetiracetam, pyrrolidone derivatives or any of the other ingredients of; this medicine (listed in Section 6). Warnings and precautions. Talk to your doctor before taking Keppra. If you suffer from kidney problems, follow your doctor’s instructions. He/she may decide if; your dose should be adjusted. palbociclib and fulvestrant protocol